封面
市場調查報告書
商品編碼
1447641

血流動力學監測設備市場- 按產品(一次性用品、監測儀)、系統類型(侵入式、微創式、非侵入式)、最終用途(醫院、門診手術中心、家庭護理機構) - 全球預測2024 - 2032

Hemodynamic Monitoring Devices Market - By Product (Disposables, Monitors), System Type (Invasive, Minimally Invasive, Non-invasive), End-use (Hospitals, Ambulatory Surgical Centers, Homecare Settings) - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 114 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於對患者血流動力學狀態持續監測的需求不斷成長,2024 年至 2032 年間,全球血流動力學監測設備市場規模將達到 5.9% 的CAGR。醫療機構越來越認知到即時監測對於改善患者治療結果的好處。加上無線連接和增強的準確性等技術進步,這些設備提供了更有效率、方便用戶使用的解決方案。

新型創新血液動力學監測設備的推出將進一步推動市場擴張,以滿足醫療保健環境中對複雜監測工具不斷成長的需求。例如,2023年4月,Vygon India推出了Mostcare Up,這是一種先進的血流動力學監測系統。這種基於微創動脈壓的監測儀利用基於壓力記錄分析方法 (PRAM) 的專利演算法來即時監測細微的血流動力學變化。

血液動力學監測設備市場分為產品、系統類型、最終用途和區域。

就系統類型而言,由於人們越來越青睞微創手術以提供縮短康復時間和縮短住院時間等好處,因此到 2032 年,微創領域的行業規模將實現 5.9% 的成長率。血流動力學監測設備透過提供患者心血管狀況的即時資料在這些手術中發揮著至關重要的作用。此外,技術進步催生了越來越攜帶和方便用戶使用的監測設備,從而加速了它們在微創外科手術中的採用。

根據最終用途,門診手術因其成本效益和便利性而日益成長,這推動了門診手術中心市場的血流動力學監測設備市場到 2032 年將實現 5.8% 的CAGR。門診手術中心 (ASC) 正在採用血流動力學監測設備來確保患者安全並最佳化手術結果。不斷進步的技術也使得這些設備更加緊湊,並且對於 ASC 設定來說更加方便用戶使用。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 全球慢性病發生率上升
      • 血流動力學監測設備的技術進步
      • 擴大採用遠端血流動力學監測設備
      • 人們越來越喜歡遠距醫療服務
    • 產業陷阱與挑戰
      • 病患監護設備成本高
      • 嚴格的監管框架
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 免洗用品
  • 顯示器

第 6 章:市場估計與預測:按系統類型,2018 年 - 2032 年

  • 主要趨勢
  • 非侵入性
  • 侵入性
  • 微創

第 7 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 家庭護理設置
  • 其他最終用戶

第 8 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Deltex Medical Group PLC
  • Edwards Lifesciences Corporation
  • GE HealthCare
  • ICU Medical, Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • OsypkaCardiotek GmbH
  • Siemens Healthineers AG
  • Sramek BioDynamics, Inc.
簡介目錄
Product Code: 7995

Global Hemodynamic Monitoring Devices Market size will register a 5.9% CAGR between 2024 and 2032, attributed to the rising demand for continuous monitoring of the hemodynamic status of patients. Healthcare facilities are increasingly recognizing the benefits of real-time monitoring for improving patient outcomes. Coupled with technology advancements, such as wireless connectivity and enhanced accuracy, these devices offer more efficient and user-friendly solutions.

The introduction of new and innovative hemodynamic monitoring devices will further propel the market expansion for catering to the rising need for sophisticated monitoring tools in healthcare settings. For instance, in April 2023, Vygon India introduced Mostcare Up, an advanced hemodynamic monitoring system. This minimally invasive arterial pressure-based monitor utilizes a patented algorithm based on the Pressure Recording Analytical Method (PRAM) for real-time monitoring of subtle hemodynamic variations.

The hemodynamic monitoring devices market is segmented into product, system type, end-use, and region.

With respect to system type, the industry size from the minimally invasive segment will witness 5.9% growth rate through 2032 due to the increasing preference for minimally invasive procedures to offer benefits, such as reduced recovery time and shorter hospital stays. Hemodynamic monitoring devices play a crucial role in these procedures by providing real-time data on a patient's cardiovascular status. Furthermore, technological advancements have resulted in the creation of monitoring devices that are increasingly portable and user-friendly, thereby accelerating their adoption in minimally invasive surgical procedures.

Based on end-use, the hemodynamic monitoring devices market from the ambulatory surgical centers segment will garner 5.8% CAGR up to 2032, driven by the increasing trend towards outpatient surgeries due to their cost-effectiveness and convenience. Ambulatory surgical centers (ASCs) are adopting hemodynamic monitoring devices to ensure patient safety and optimize surgical outcomes. Rising technological advancements have also made these devices more compact and user-friendly for ASC settings.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Technological advancements in hemodynamic monitoring devices
      • 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
      • 3.2.1.4 Growing preference for telehealth services
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of patient monitoring devices
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Disposables
  • 5.3 Monitors

Chapter 6 Market Estimates and Forecast, By System Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Non-invasive
  • 6.3 Invasive
  • 6.4 Minimally invasive

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Homecare settings
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Baxter International Inc.
  • 9.3 Deltex Medical Group PLC
  • 9.4 Edwards Lifesciences Corporation
  • 9.5 GE HealthCare
  • 9.6 ICU Medical, Inc.
  • 9.7 Koninklijke Philips N.V.
  • 9.8 Masimo Corporation
  • 9.9 Medtronic plc
  • 9.10 Nihon Kohden Corporation
  • 9.11 OsypkaCardiotek GmbH
  • 9.12 Siemens Healthineers AG
  • 9.13 Sramek BioDynamics, Inc.